- JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary
-
Kwak C
- KMID: 2553938
- J Urol Oncol.
- 2024 Mar;22(1):1-3.
- doi: 10.22465/juo.24edi001
-
- CITED
-
- Close
- SHARE
-
- Close
- Declaration of Conflict of Interest for Editorial Board Members’ Articles
-
Editorial Office, Korean Urological Oncology Society
- KMID: 2553949
- J Urol Oncol.
- 2024 Mar;22(1):95-96.
- doi: 10.22465/juo.2024.err01
-
- CITED
-
- Close
- SHARE
-
- Close
- Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
-
Jeong CW
- KMID: 2553939
- J Urol Oncol.
- 2024 Mar;22(1):4-10.
- doi: 10.22465/juo.244600220011
Prostate cancer (PCa) is the second most common cancer globally. However, significant disparities in incidence and mortality exist between countries, especially between Western and Asian regions. This review discusses the... -
- CITED
-
- Close
- SHARE
-
- Close
- Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
-
Kim SH, Savul IS, Lerner SP
- KMID: 2553947
- J Urol Oncol.
- 2024 Mar;22(1):68-77.
- doi: 10.22465/juo.244600180009
Radical nephroureterectomy (RNU) remains the gold standard for the surgical management of upper tract urothelial carcinoma (UTUC) from the ureterovesical junction to the renal pelvis. However, the removal of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
-
Suh M, Cheon GJ
- KMID: 2553940
- J Urol Oncol.
- 2024 Mar;22(1):11-20.
- doi: 10.22465/juo.244600200010
In managing prostate cancer, the integration of multidisciplinary team (MDT) with prostate-specific membrane antigen (PSMA) theranostics marks a significant advancement, addressing the disease's spectrum from indolent forms to aggressive metastatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
-
Kim JH, Hwang JW
- KMID: 2553944
- J Urol Oncol.
- 2024 Mar;22(1):42-51.
- doi: 10.22465/juo.244600120006
Purpose: Renal cell carcinoma (RCC) is a relatively common malignancy of the urinary tract. Over the past few decades, methodologies for diagnosing and managing patients with RCC have shown various... -
- CITED
-
- Close
- SHARE
-
- Close
- Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study
-
Lim SH, Cho SW, Chung JH, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Park SH
- KMID: 2553942
- J Urol Oncol.
- 2024 Mar;22(1):29-33.
- doi: 10.22465/juo.244600040002
Purpose: To assess the feasibility and short-term efficacy of maintenance enzalutamide following first-line docetaxel plus androgen deprivation therapy (ADT) in patients with high-volume, metastatic castration-naive prostate cancer (mCNPC). Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
-
Frost S, Ziarati P, Moen R, Kysh L, Johnson R, Pearce S, Daneshmand S, Siegmund KD, Cortessis VK
- KMID: 2553948
- J Urol Oncol.
- 2024 Mar;22(1):78-94.
- doi: 10.22465/juo.244600020001
Purpose: Diabetes mellitus, a frequent comorbid condition in cancer patients, has been shown to increase risk of all-site cancer mortality. This relationship has not been systematically studied in bladder cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
-
Hong J, Kwon GY, Kang M, Seo SI, Park SH
- KMID: 2553946
- J Urol Oncol.
- 2024 Mar;22(1):59-67.
- doi: 10.22465/juo.234600660033
Purpose: TFE3-rearranged/TFEB-altered renal cell carcinoma (RCC) is a rare subtype of RCC. Due to its rarity, there is an unmet medical need for effective therapies in advanced settings. The study... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study
-
Choi SK, Kim M, Lee SM, Song C, Hong JH, Kim CS, Ahn H
- KMID: 2553941
- J Urol Oncol.
- 2024 Mar;22(1):21-28.
- doi: 10.22465/juo.244600080004
Purpose: To find out the incidence and predictors for late high-grade genitourinary (GU) toxicity following salvage radiotherapy (SRT), we investigated the consecutive patients who were treated with SRT after radical... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center
-
Lee HY, Kim Y, Lim B, You D, Song C, Jeong IG, Hong B, Hong JH, Ahn H, Suh J
- KMID: 2553945
- J Urol Oncol.
- 2024 Mar;22(1):52-58.
- doi: 10.22465/juo.234600600030
Purpose: This study investigated the prognostic factors and cancer-specific survival (CSS) of patients who had renal cell carcinoma (RCC) with venous thrombus and underwent radical nephrectomy with thrombectomy (RNTx). Materials and... -
- CITED
-
- Close
- SHARE
-
- Close
- Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
-
Gu HM, Jung SI, Kwon D, Kim MH, Jung JH, Han MA, Lee SH, Jeong IG, Kim SI, Hwang EC
- KMID: 2553943
- J Urol Oncol.
- 2024 Mar;22(1):34-41.
- doi: 10.22465/juo.244600140007
Purpose: The aim of this study was to assess the effects of tyrosine kinase inhibitors (TKIs) following metastasectomy in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods: A systematic... -
- CITED
-
- Close
- SHARE
-
- Close
